News & Updates

Semaglutide reduces CV risk in overweight/obese patients without T2D

21 Nov 2023 by

Treatment with semaglutide reduced the risk of major adverse cardiovascular events (MACE) among overweight/obese patients with pre-existing cardiovascular (CV) disease but without type 2 diabetes (T2D), according to the SELECT trial presented at AHA 2023.

Semaglutide reduces CV risk in overweight/obese patients without T2D

21 Nov 2023

8-week TAF course enough to prevent mother–child HBV transmission

20 Nov 2023 by

An 8-week course is as good as a 12-week course of tenofovir alafenamide fumarate (TAF) therapy in terms of preventing the transmission of hepatitis B virus (HBV) infection from mothers to infants, as reported in a study.

8-week TAF course enough to prevent mother–child HBV transmission

20 Nov 2023

Chronic HBV infection may up risk of intracerebral haemorrhage

17 Nov 2023

Chronic hepatitis B virus (HBV) infection appears to put Chinese adults at higher risk of intracerebral haemorrhage but not other stroke subtypes, as reported in a study.

Chronic HBV infection may up risk of intracerebral haemorrhage

17 Nov 2023

Early life antibiotic, acid suppressant exposure linked to eosinophilic esophagitis in childhood

15 Nov 2023

Maternal and infant use of antibiotic and acid suppressants appears to contribute to an increased risk of eosinophilic esophagitis in a dose-response manner, with the association being strongest when exposed to the medications near the time of delivery, according to a study.

Early life antibiotic, acid suppressant exposure linked to eosinophilic esophagitis in childhood

15 Nov 2023

Osemitamab plus CAPOX proven safe, prolongs survival in advanced G/GEJ cancer

15 Nov 2023 by

First-line treatment with TST001 (osemitamab) in combination with capecitabine and oxaliplatin (CAPOX) is safe and well tolerated in patients with advanced gastric/gastroesophageal junction (G/GEJ) cancer, according to a study presented at ESMO 2023.

Osemitamab plus CAPOX proven safe, prolongs survival in advanced G/GEJ cancer

15 Nov 2023

Thalidomide reduces recurrent GI bleeding in patients with small-intestinal angiodysplasia

15 Nov 2023 by

Among patients with recurrent gastrointestinal (GI) bleeding due to small-intestinal angiodysplasia (SIA), treatment with thalidomide resulted in fewer bleeding episodes compared with placebo, according to a recent study.

Thalidomide reduces recurrent GI bleeding in patients with small-intestinal angiodysplasia

15 Nov 2023

Original New Drug Application Approvals by US FDA (01-15 November 2023)

15 Nov 2023

New drug applications approved by US FDA as of 01-15 November 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (01-15 November 2023)

15 Nov 2023

Does intermittent fasting reduce acid exposure in GERD patients?

06 Nov 2023

Patients with suspected gastroesophageal reflux disease (GERD) may find it difficult to follow a time-restricted eating, reports a study. Additionally, there is weak evidence to suggest that intermittent fasting helps ease acid exposure.

Does intermittent fasting reduce acid exposure in GERD patients?

06 Nov 2023

Which DOAC is best for gastrointestinal haemorrhage in atrial fibrillation patients?

05 Nov 2023

Use of apixaban appears to reduce the risk of gastrointestinal haemorrhage (GIH) compared with dabigatran, rivaroxaban, and vitamin K antagonist (VKA) in patients with nonvalvular atrial fibrillation, a recent study has shown. On the other hand, rivaroxaban use tends to increase GIH risk relative to dabigatran and VKA.

Which DOAC is best for gastrointestinal haemorrhage in atrial fibrillation patients?

05 Nov 2023

IBS symptoms tied to depression, anxiety in NAFLD patients

04 Nov 2023

Patients with nonalcoholic fatty liver disease (NAFLD) tend to have higher rates of irritable bowel syndrome (IBS) symptoms, depression, and anxiety, suggests a study.

IBS symptoms tied to depression, anxiety in NAFLD patients

04 Nov 2023

News & Updates

Filter by Specialty:

Specialty:

Semaglutide reduces CV risk in overweight/obese patients without T2D

Semaglutide reduces CV risk in overweight/obese patients without T2D

8-week TAF course enough to prevent mother–child HBV transmission

8-week TAF course enough to prevent mother–child HBV transmission

Chronic HBV infection may up risk of intracerebral haemorrhage

Chronic HBV infection may up risk of intracerebral haemorrhage

Early life antibiotic, acid suppressant exposure linked to eosinophilic esophagitis in childhood

Early life antibiotic, acid suppressant exposure linked to eosinophilic esophagitis in childhood

Osemitamab plus CAPOX proven safe, prolongs survival in advanced G/GEJ cancer

Osemitamab plus CAPOX proven safe, prolongs survival in advanced G/GEJ cancer

Thalidomide reduces recurrent GI bleeding in patients with small-intestinal angiodysplasia

Thalidomide reduces recurrent GI bleeding in patients with small-intestinal angiodysplasia

Original New Drug Application Approvals by US FDA (01-15 November 2023)

Original New Drug Application Approvals by US FDA (01-15 November 2023)

Does intermittent fasting reduce acid exposure in GERD patients?

Does intermittent fasting reduce acid exposure in GERD patients?

Which DOAC is best for gastrointestinal haemorrhage in atrial fibrillation patients?

Which DOAC is best for gastrointestinal haemorrhage in atrial fibrillation patients?

IBS symptoms tied to depression, anxiety in NAFLD patients

IBS symptoms tied to depression, anxiety in NAFLD patients